Change over period: —
NSE · THEMISMED
THEMIS MEDIC
-27.5% from the 52-week high · +46.1% above the low
Themis Medicare Ltd. is a holding company, which engages in the manufacture of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 1,145 full-time employees. The company went IPO on 2007-04-02. The firm operates through one segment: Pharmaceuticals. The firm manufactures therapeutic pharma products, differential healthcare products, and APIs based in India. Its analgesic and anti-inflammatory products include Aquadol Tpm Gel, Etojet 90 10'S, Etojet 120 10'S, Etojet Mr Tablets 10'S, Etojet XP Gel, Themidol-P Tab 10's, Dhoom, Aquadol inj, Dyloaqua inj, Joydol -P, Joydol -SP, Joydol -TH, and Nimujet Gel. Its Analgesics products include Anemol, Tazowin, Themidol, Themidol. Its Anesthesia products include Bupicaine 0.25%, Ketmin 2 Vial, Ketmin 5, Ropicaine 2, Themicaine 2%, and more. Its subsidiaries include Artemis Biotech Limited, Themis Lifestyle Private Limited, and Carpo Medical Limited (UK).
The short version. THEMIS MEDIC reported revenue of ₹90 crore for Sep 2026, up 15.4% from a year earlier. Net profit was ₹7 crore. Return on equity was 0.3% in Mar 2026. Promoter holding was 67.1% in Sep 2026, down 0.05 points over 8 quarters.
1 · The price
How has the stock traded?
THEMIS MEDIC trades 27.5% below its 52-week high and 46.1% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹90 cr.
12.5 pts higher than a year earlier.
Revenue compounded at -1.3% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 90 | 87 | 77 | 90 | 78 | 98 | 72 | 94 |
| Net profit | 7 | 25 | 9 | 10 | -4 | -14 | -10 | 1 |
| Net margin % | 7.9 | 28.3 | 11.6 | 11.2 | -4.6 | -14.6 | -13.5 | 0.6 |
| EPS (₹) | 0.77 | 2.67 | 0.96 | 1.1 | -0.39 | -1.55 | -1.05 | 0.06 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 342 | 406 | 382 | 354 | 395 | 231 | 202 | 184 |
| Net profit | 1 | 30 | 44 | 57 | 73 | 36 | 25 | -11 |
| Net margin % | 0.3 | 7.4 | 11.4 | 16.1 | 18.5 | 15.5 | 12.3 | -5.8 |
| EPS (₹) | 0.12 | 3.24 | 4.73 | 6.18 | 7.92 | 3.89 | 2.7 | -1.17 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 0.3% in Mar 2026; debt to equity is 0.25.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 0.3 | 7.4 | 11.5 | 16.8 |
| Return on capital % | -0.3 | 10.1 | 10.7 | 18.3 |
| EBITDA margin % | 2.5 | 13.1 | 14.6 | 21.6 |
| Net margin % | 0.3 | 7.3 | 11.3 | 15.6 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | -1.3% | 8.5% |
| Profit CAGR | -72.8% | -49.8% |
4 · The owners
Who holds it, and are they adding?
Down 0.05 pts over 8 quarters.
Down 0.09 pts over 8 quarters.
Unchanged over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 67.15 | 67.15 | 67.15 | 67.15 | 67.1 | 67.1 | 67.1 | 67.1 | -0.05 |
| FII | 0.1 | 0.14 | 0.1 | 0.06 | 0.05 | 0.11 | 0.01 | 0.01 | -0.09 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.0 |
| Public | 32.74 | 32.7 | 32.74 | 32.78 | 32.83 | 32.78 | 32.87 | 32.87 | +0.13 |
Mutual fund holdings · Oct 2026
2 schemes hold this stock
2 the month before.
- Motilal Oswal BSE Healthcare ETF0.02% of NAV
- Bandhan BSE Healthcare Index Fund0.02% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for THEMIS MEDIC are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about THEMIS MEDIC
What is the THEMIS MEDIC share price?
THEMIS MEDIC (THEMISMED) last closed at ₹97.24, up 0.77% on the day. Its 52-week range is ₹66.07 to ₹133.07.
What is the market cap of THEMIS MEDIC?
THEMIS MEDIC has a market capitalisation of about ₹885 crore. Its price-to-earnings ratio is 22.3.
How are THEMIS MEDIC's latest results?
THEMIS MEDIC reported revenue of ₹90 crore for Sep 2026, up 15.4% from a year earlier. Net profit was ₹7 crore. Return on equity was 0.3% in Mar 2026. Promoter holding was 67.1% in Sep 2026, down 0.05 points over 8 quarters.
Who owns THEMIS MEDIC?
As of Sep 2026, shareholding was: Promoter 67.1%, FII 0.01%, DII 0.01%, Public 32.87%.
How many mutual funds hold THEMIS MEDIC?
2 mutual fund schemes held THEMIS MEDIC in October 2026. That compares with 2 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 04 Sep 2025 · Final Dividend - Rs. 0.5
- 12 Jul 2024 · Final Dividend - Rs. 0.5
- 10 Oct 2023 · Stock Split From Rs.10/- to Rs.1/-
- 01 Sep 2023 · Final Dividend - Rs. 5
- 08 Sep 2022 · Final Dividend - Rs. 5
- 08 Sep 2021 · Final Dividend - Rs. 4.3
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.